Viome Life Sciences Secures $86.5M for At-home Tests and Health Products
Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures. In total, Viome has raised $175 million.
Viome Life Sciences snags $67M to expand DTC pipeline of at-home tests and wellness products
The funding was led by Bold Capital Group. Other investors of the company include Khosla Ventures, WestRiver Group and Glico. In total, Viome has raised more than $150 million.
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Viome Life Sciences launches at-home oral/throat cancer test for consumers
The saliva-based test has been found to have 95% specificity and 90% sensitivity. Consumers can purchase it online and have it shipped to their house.